PHARMACODYNAMIC INTERACTION BETWEEN NIFEDIPINE AND SODIUM VALPROATE AGAINST KAINIC ACID-INDUCED CONVULSOINS IN MICE دراسة التفاعالت الديناميکية الدوائية بين عقارى النيفيديبين وفالبروات الصوديوم ضد النوبات الصرعية المحدثة بمادة حامض الکاينيک فى الفئران

Document Type : Original Article

Abstract

ABSTRACT :
In the present study, the possible pharmacodynamic interaction between nifedipine (30
mg/kg,i.p) and sodium valproate (300 mg/kg,i.p) against kainic acid (70 mg/gk, i.p) was
evaluated in mice. The seizures onset of kainic acid (KA), the percent of mice surviving
KA-induced seizures and the mean survival time (MST) of mice were determined 30 minutes
after single and combined administration of nifedipine and sodium valporate (VAL). The
above mentioned three parameters of KA-induced seizures were determined in a control
group of mice receiving saline solution.
In a second set of experiments, the serum and brain Na+, Ca2+ and K+ ion contents were
determined after single i.p. administration of KA, nifedipine and VAL. Two lesser than the
MST of mice receiving KA, mice were given nifedipine plus KA, VAL plus KA and
nifedipine plus VAL and KA. Serum and brain tissue samples were taken from all groups of
mice and were analysed for their content of Na+, Ca2+ and K+ ion
Results of this study revealed that the i.p injection of KA into mice led to the appearance
of convulsions (seizure onset) after 6.06 minutes and a MST of mice of 7.82. minutes. This
convulsive effect was associated with significant increase in brain Na+ and Ca+2 levels as well
as significant lowering of brain K+ concentration. Our results also indicated that the i.p.
injection of nifedipine into mice produced significant increase in the seizure onset of KA
action and the MST of mice as well as, the percent protection of mice to a value of 25%. The
anticonvulsant action of VAL was accompanied by a significant increase in the serum Na+ and
Ca2+ contents and an elevated brain K+ level.
In addition, our results indicated that the single i.p injection of VAL elicited significant
increases in the onset of KA-induced seizures, the MST of mice as well the KA-induced 
mortality by a factor of 50%. This effect was correlated with an increase in the serum Na+,
lowered brain Na+ and an increased brain K+.
The combined administration of nifedipine and VAL was found to protect all animals
from KA-induced death. This 100% protection was associated with 4-fold increase in the onset
of KA-induced seizures. Measurement of the serum and brain electrolytes in mice receiving
the combination of nifedipine and VAL demonstrated that this combination caused
significant diminution of brain Na+ and Ca2+ ions and a rise in brain K+ ions.
It may be the ability of nifedipine to reduce brain Na+ and Ca2+ concentration which is the
factor responsible for the additive anticonvulsant effect recorded after the combined
administration of nifedipine and sodium valproate
فى ھذا البحث تم دراسة التفاعالت الديناميکية الدوائية المحتملة بين عقارى النيفيديبين
وفالبروات الصوديوم ضد النوبات الصرعية المحدثة بواسطة مادة حامض الکاينيک .
-وتم قياس الزمن الالزم لظھور النوبات التشنجية ونسبة الموت فى حيوانات التجارب باإلضافة إلى
متوسط األزمنة التى تبقى فيه الفئران حيه بعد حقن مادة حامض الکاينيک لوحدھا وبعد مرور
٣٠ دقيقة من حقن کل من النيفيدبين وفالبروات الصوديوم کل على حده أو فى تعاطى مشترک.
- وکذلک تم قياس مستوى أيونات الصوديوم والکالسيوم والبوتاسيوم فى مصل ومخ الفئران بعد
الحقن البريتونى لکل من حامض الکاينيک والنيفيديبن وفالبروات الصوديوم قبل انتھاء زمن بقاء
الحيوانات حيه وعقب حقنھا بحامض الکاينيک بدقيقتين .
- أظھرت النتائج أن حقن حامض الکاينيک فى الفئران يؤدى إلى ظھور نوبات صرعية بعد زمن
٦٫٠٦ دقيقة من حقن المادة وأن متوسط زمن بقاء الحيوانات حيه قد وصل إلى ٧٫٨٢ دقيقة.
ً أن ھذه النوبات الصرعية تکون مصحوبة بزيادة ملحوظة فى مستوى
وأظھرت النتائج أيضا
الصوديوم والکالسيوم ونقص فى مستوى البوتاسيوم فى مخ الفئران. وکذلک يؤدى إلى زيادة نسبية
فى الزمن الالزم لبدء حدوث النوبات الصرعية وزمن بقاء الحيوانات حيه باالضافة إلى زيادة فى
نسبة حماية الحيوانات من الموت بعد حقن مادة حامض الکاينيک (٢٥%).
ً فإن ھذه الدراسة أثبتت أن حقن مادة فالبروات الصوديوم بمفردھا قد أدى إلى زيادة نسبية فى
- أيضا
الزمن الالزم لظھور النوبات التشنجية للفئران وزمن بقاء الحيوانات حيه عقب حامض الکاينيک ھذا
باالضافة إلى زيادة فى نسبة حماية الحيوانات من الموت بنسبة ٥٠%. وقد کانت ھذه التأثيرات
المضادة للتشنج مصحوبة بزيادة فى مستوى الصوديوم فى مصل الفئران ونقص فى مستوى
الصوديوم والکالسيوم وزيادة فى مستوى البوتاسيوم فى المخ.
وعند الحقن المشترک لعقارى النفيديبين وفالبروات الصوديوم أدى ذلک إلى حماية کل حيوانات
التجارب من الموت المحدث بحامض الکاينيک مع زيادة فى الزمن الالزم لبدء حدوث النوبات
مصحوبا بنقص فى مستوى الصوديوم والکالسيوم وزيادة فى مستوى ً التشنجية وکان ھذا التأثير
البوتاسيوم فى مخ الفئران.

REFRENCES :
1-Katzung, B.G.: Basic and Clinical
Pharmacology 6th ed. Prentice Hall.
International Inc. London, UK, 1994, PP.
180.
2-Kryzhanovskii, G.N., Karpova, M.N.,
Abrosimov, U.V., Pankov, Olu., and
Lakinina, M.V.: Anticonvulsant activity of
sodium valproate and various calcium
antagonists during their combined use in
mice. Bull. Eksp. Biol. Med., 115(3): 231
(1993).
3-Tussel, J.M., Barron, S., and Seatosa, J.
Anticonvulsant activity of
delta-HcH-calcium-channel blockers and
calmodulin antagonists in seizures induced
by lindane and other convulsant drugs. Brain
Research, 17, 622 (1-2): 99-104 (1993).
4-Gasior, M., Kaminski, R., Brudniak, T.,
Kleinron, Z. and CzucZwar, S.J: Influence of
nicardipine, nimodipine and flunatizine on
the anticonvulsant efficacy of antiepileptics
against pentylenetetazole in mice. J. Neurol.
Transm. Gen. Sect. 103(7): 819-831(1996).
5- Jagiello-Wojtowicz, E., CzucZwar, S.J,
Chodkowska, A., Szponar, J. and Kleinrok,
z.: Influence of calcium channel blockers on
pentylenetetrazole and electroshock-induced
convulsions in mice. Poland. J. of Pharm.
and Pharmacol., 43,95-101(1991).
6-Palmer, G.C, Stagnitto, M.L., Ray, R.K.
Knowles, M.A., Harvery R. and Garske, G.E.
Anticonvulsant properties of calcium channel
blockers in mice. Epilepsia, 34 (2):
372-380(1993).
7-Kamal, J.A., Nadig, R.S., Joseph, T. and
David, J. : Effect of calcium channel blockers
on experimentally-induced seizures in rats.
Ind. J. of Exp. Bio., 28 (7): 605-608 (1990).
8-Wong, W.S. and Rahwan, R.G. Examination
of the potential antiepileptic activity of
calcium antagonists with diffe-rent sites of
action. Gene. Pharmacol. 20(3): 309-312
(1989).
9-Karpova, M.N.; Pankov, O.K., Gelbov, R. N.,
Germane, S.K., Klusha, V.E. and Duburg,
L.A. effect of calcium channel blocker
ryodipine on focal and generalized epileptic
activity Bull. Eskp. Biol. Med. 108 (11) :
553-555 (1989) .
10-CzucZwar S.J., Chodkowska, A., Kleinrok,
Z., Malex, U., and Jagillo-Wojtowicz, E.:
Effect of calcium channel inhibitors upon the
efficacy of common antiepileptic drugs.
Europ. J. of Pharmacol., 25, 126(1): 75-83;
(1990 (a)).
11-CzucZuar, S.J, Malex, U. and Kleinrok, Z.:
Influence of calcium channel inhibitors upon
the anticonvulsant efficacy of common
antiepileptics against 
pentylenetetrazole-induced convulsions in
mice. Neuro., 29 (10): 943-948 (1990 b).
12-Gram, A. and Bentsen, K.: Valproate: An
updated review. Acta Neurologica Scand.,
72: 129-139 (1985).
13-Chambon, J.P., Molimard, J.C., Calassi, R.,
Maruani, J., Rodier, D., Sigault G., Leyris,
R., Roncucci, R. and Biziere K.:
Anticonvulsant activity of
4,9-Dioxo-5,10-diazatetradecane (CM 40140),
a new GABA derivative, in mice and
photosensitive baboons. Arzneimettel
Forshung/Drug Res., 34 (II): 1017-1021
(1984).
14-Snedcor, G. and Cochran, W.: Statistical
Methods, 6th ed. Iowa state University Press,
Iowa, USA (1967).
15-Lotherman, E.W., Collins, R.C. and Ferren
delli, J.A.: Kainic acid-induced limbic
seizures: Electrophysiologic studies.
Neurology, 31: 806-812(1981).
16-Mubhof, U., Madeja, M. Bolms-Funke, P.,
Speckmann, E.J: Effects of epileptogenic
agent bicuculline methoidide on membrane
currents induced by N-methyl -D- aspartate
and kainate. Brain Res., 639: I 35-138:
(1994).
17-Lux, H.D. and Heinemann, U.: Ionic changes
during experimentally -induced seizure
activity. Electroencephalograph and Clinical
Neurophysiology (suppl.), 34: 289-297 (1978).
18-Rutecki, P.A., lebeda, F.J. and Johnston, D.:
Epileptiform activity induced by changes in
extracellular potassium in hippocampus. J.
of Neurophysiol, 54(5): 1363-1374: (1985).
19-Kudo, Y. and Ogura, A: Glutamate-induced
increase in intracellular calcium
concentration in isolated hippocampal
neurons. Bri. J. of Pharmacol., 89(1): 191-198
(1986).
20-Walden, J., Straub, H. and Speckmann, E.J.:
Epileptogenesis: Contribution of calcium
ions to the generation of epileptic activity
and antiepileptic calcium antagonism.
Neuropsychobiology, 27(3): 122-126 (1993).
21-Speckmann, E.J., Straub, H., Kohling, R.:
Contribution of calcium ions to the
generation of epileptic activity and
antiepileptic calcium antagonism.
Neuropsychobiology, 27(3): 122-126 (1993).
22-Shibuya, T. and Watanabe Y. : Central
effects of calcium channel blockers: multiple
sites of action, Nippon-Yakurigaku-Zasshi,
100(3): 239-247 (1992).
23-Ene, H.D., Williamson, P.J., Roberts, J.C.,
and Waddel, C.G: The natriuresis following
oral administration of the calcium
antagonists nifedipine and nitrendipine. Br.
J. of Clin. Pharmacol., 19: 423-427 (1985).